Williams & Novak’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Williams & Novak's PBYI Position: Q3 2026 in Review
Williams & Novak sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 10,489 shares — an estimated $85.1K sold.
Williams & Novak first reported a position in PBYI in Q1 2025 and held it in 5 quarters. The position peaked at $85.1K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Williams & Novak reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
- Williams & Novak sold 10,489 Puma Biotechnology shares in Q3 2026, an estimated $85.1K.
- Williams & Novak first reported a position in Puma Biotechnology in Q1 2025 and held it in 5 quarters.
- Williams & Novak's Puma Biotechnology position peaked at $85.1K in Q2 2026.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.